Ermeza Oral Liquid Product

RxNorm concept 2626054, branded dose form group (sbdg).

RxCUI: 2626054
Term type: Branded dose form group (SBDG)
Status: Active

Request

curl https://api.healthcare.dev/v1/drugs/rxnorm/2626054 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Concept

Ingredients and related concepts

Ingredients

levothyroxine 10582

Related concepts

Ermeza (BN, has ingredient)
levothyroxine Oral Liquid Product (SCDG, tradename of)
levothyroxine sodium Oral Liquid Product (SCDGP, tradename of)

Linked data

NDCs

RxNorm links no NDCs to this concept.

Use it

Look up 2626054 from code or an agent

curl

curl https://api.healthcare.dev/v1/drugs/rxnorm/2626054 \
  -H "Authorization: Bearer $HDEV_API_KEY"

MCP prompt

Using the healthcare.dev MCP server, look up RxNorm concept 2626054. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.

Get a free key RxNorm docs Connect the MCP server

Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.